miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2020;70(2020):7–30.
   PubMedGoogle Scholar
• Jemal A, Ward EM, Johnson CJ, et al. Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Natl Cancer Inst. 2017;109(9). DOI:10.1093/jnci/djx030
   Google Scholar
• Laengsri V, Kerdpin U, Plabplueng C, et al. Cervical cancer markers: epigenetics and microRNAs. Lab Med. 2018;49(2):97–111.
   PubMed Web of Science ®Google Scholar
• Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15(8):509–524.
   PubMed Web of Science ®Google Scholar
• Croce CM, Calin GA. miRNAs, cancer,and stem cell division. Cell. 2005;122(1):6–7.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang L, Chen C, et al. New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications. Mol Cancer. 2018;17(1):22.
   PubMedGoogle Scholar
• L. Ning M, Zhang Q, Zhu F, et al. miR-25-3p inhibition impairs tumorigenesis and invasion in gastric cancer cells in vitro and in vivo. Bioengineered. 2020;11(1):81–90.
   PubMed Web of Science ®Google Scholar
• Han B, Ge Y, Cui J, et al. Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis. Bioengineered. 2020;11(1):524–535.
   PubMed Web of Science ®Google Scholar
• Liu C, Wang J, Hu Y, et al. Upregulation of kazrin F by miR-186 suppresses apoptosis but promotes epithelial-mesenchymal transition to contribute to malignancy in human cervical cancer cells. Chin J Cancer Res. 2017;29(1):45–56.
   PubMed Web of Science ®Google Scholar
• Liu Y, Guo R, Qiao Y, et al. LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis. Cancer Cell Int. 2020;20(1):190.
   PubMed Web of Science ®Google Scholar
• He M, Jin Q, Chen C, et al. The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells. Oncogene. 2019;38(28):5551–5565.
   PubMed Web of Science ®Google Scholar
• Murray PG, Clayton PE. Endocrine control of growth, American journal of medical genetics. Part C, Seminars in medical genetics, 163c (2013) 76–85. doi: 10.1002/ajmg.c.31357
   Google Scholar
• Sharma M, Satyam A, Abhishek A, et al. Molecular and circulatory expression of insulin growth factors in Indian females with advanced cervical cancer. Asian Pac J Cancer Prev. 2012;13(12):6475–6479.
   PubMedGoogle Scholar
• Lee SW, Lee SY, Lee SR, et al. Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia. J Gynecol Oncol. 2010;21(3):174–180.
   PubMed Web of Science ®Google Scholar
• Shen MR, Hsu YM, Hsu KF, et al. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling. Carcinogenesis. 2006;27(5):962–971.
   PubMed Web of Science ®Google Scholar
• Renehan AG, Zwahlen M, Minder C, et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363(9418):1346–1353.
   PubMed Web of Science ®Google Scholar
• Wang R, Bao H, Zhang S, et al. miR-186-5p promotes apoptosis by targeting IGF-1 in SH-SY5Y OGD/R Model. Int J Biol Sci. 2018;14(13):1791–1799.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Zhuang Z, q Xiao H, Hu S, et al. Down-regulation of microRNA-155 attenuates retinal neovascularization via the PI3K/Akt pathway. Mol Vis. 2015;21:1173–1184.
   PubMed Web of Science ®Google Scholar
• Guo L, Fu J, Sun S, et al. MicroRNA-143-3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3. Cancer Sci. 2019;110(2):805–816.
   PubMed Web of Science ®Google Scholar
• Yang ZC, Ma J. Actein enhances TRAIL effects on suppressing gastric cancer progression by activating p53/Caspase-3 signaling. Biochem Biophys Res Commun. 2018;497(4):1177–1183.
   PubMed Web of Science ®Google Scholar
• Geng X, Sun Y, Fu J, et al. MicroRNA-17-5p inhibits thyroid cancer progression by suppressing Early growth response 2 (EGR2). Bioengineered. 2021;12(1):2713–2722.
   PubMed Web of Science ®Google Scholar
• Lal A, Thomas MP, Altschuler G, et al. Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PLoS Genet. 2011;7(11):e1002363.
   PubMed Web of Science ®Google Scholar
• Song W, Zhang T, Yang N, et al. Inhibition of micro RNA miR-122-5p prevents lipopolysaccharide-induced myocardial injury by inhibiting oxidative stress, inflammation and apoptosis via targeting GIT1. Bioengineered. 2021;12(1):1902–1915.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu C, Xie Z, et al. Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway. Chem Biol Interact. 2020;317:108960.
   PubMed Web of Science ®Google Scholar
• Hu GF, Wang C, Hu GX, et al. AZD3463, an IGF-1R inhibitor, suppresses breast cancer metastasis to bone via modulation of the PI3K-Akt pathway. Ann Transl Med. 2020;8(6):336.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Wu C, Yang J, et al. Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer. Signal Transduct Target Ther. 2020;5(1):53.
   PubMed Web of Science ®Google Scholar
• Cai J, Wu J, Zhang H, et al. miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res. 2013;73(2):756–766.
   PubMed Web of Science ®Google Scholar
• Chen F, Zhou C, Lu Y, et al. [Expression of hsa-miR-186 and its role in human colon carcinoma cells]. Nan Fang Yi Ke Da Xue Xue Bao. 2013;33:654–660.
   PubMedGoogle Scholar
• Zhang TJ, Wang YX, Yang L, et al. Down-regulation of mir-186 correlates with poor survival in de novo acute myeloid leukemia. Clin Lab. 2016;62(1+02/2016):113–120.
   PubMed Web of Science ®Google Scholar
• He W, Feng J, Zhang Y, et al. microRNA-186 inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma by targeting SKP2. Lab Invest. 2016;96(3):317–324.
   PubMed Web of Science ®Google Scholar
• Yao K, He L, Gan Y, et al. MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1. Diagn Pathol. 2015;10(1):146.
   PubMedGoogle Scholar
• Liu L, Wang Y, Bai R, et al. MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α regulation. Oncogenesis. 2016;5(5):e224.
   PubMedGoogle Scholar
• Ruan T, He X, Yu J, et al. MicroRNA-186 targets Yes-associated protein 1 to inhibit Hippo signaling and tumorigenesis in hepatocellular carcinoma. Oncol Lett. 2016;11(4):2941–2945.
   PubMed Web of Science ®Google Scholar
• Wang Z, Sha HH, Li HJ. Functions and mechanisms of miR-186 in human cancer. Biomed Pharmacother. 2019;119:109428.
   PubMed Web of Science ®Google Scholar
• Cui G, Cui M, Li Y, et al. MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells. Tumour Biol. 2014;35(9):8933–8937.
   PubMedGoogle Scholar
• Zhang JJ, Wang DD, Du CX, et al. Long noncoding rna anril promotes cervical cancer development by acting as a sponge of miR-186. Oncol Res. 2018;26(3):345–352.
   PubMed Web of Science ®Google Scholar
• Javed S, Bhattacharyya S, Bagga R, et al. Insulin growth factor-1 pathway in cervical carcinoma cancer stem cells. Mol Cell Biochem. 2020;473(1–2):51–62.
   PubMed Web of Science ®Google Scholar
• Han T, Zhou Y, Li D. Relationship between hepatocellular carcinoma and depression via online database analysis. Bioengineered. 2021;12(1):1689–1697.
   Google Scholar
• Zhang L, Zhou F, ten Dijke P. Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer. Trends Biochem Sci. 2013;38(12):612–620.
   PubMed Web of Science ®Google Scholar
• Zhou X, Chen Z, Pei L, et al. MicroRNA miR-106a-5p targets forkhead box transcription factor FOXC1 to suppress the cell proliferation, migration, and invasion of ectopic endometrial stromal cells via the PI3K/Akt/mTOR signaling pathway. Bioengineered. 2021;12(1):2203–2213.
   PubMed Web of Science ®Google Scholar
• Janku F, Yap TA, Meric-Bernstam F. Targeting the PI3K pathway in cancer: are we making headway? Nat Rev Clin Oncol. 2018;15(5):273–291.
   PubMed Web of Science ®Google Scholar
• Yang J, Nie J, Ma X, et al. Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer. 2019;18:26.
   PubMed Web of Science ®Google Scholar
• Wang L, Liu Y, Zhou Y, et al. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways. J Exp Clin Cancer Res. 2019;38(1):93.
   PubMedGoogle Scholar
• Liao S, Xiao S, Zhu G, et al. CD38 is highly expressed and affects the PI3K/Akt signaling pathway in cervical cancer. Oncol Rep. 2014;32(6):2703–2709.
   PubMed Web of Science ®Google Scholar
• Lee CM, Fuhrman CB, Planelles V, et al. Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines. Clin Cancer Res off J Am Assoc Cancer Res. 2006;12(1):250–256.
   PubMed Web of Science ®Google Scholar
• Zhang XY, Zhang HY, Zhang PN, et al. Elevated phosphatidylinositol 3-kinase activation and its clinicopathological significance in cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2008;139(2):237–244.
   PubMed Web of Science ®Google Scholar
• Li R, Song Y, Zhou L, et al. Downregulation of RAGE inhibits cell proliferation and induces apoptosis via regulation of PI3K/AKT pathway in cervical squamous cell carcinoma. Onco Targets Ther. 2020;13:2385–2397.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhou J, Qin X, et al. Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGF-β1-mediated PI3K and MAPK pathways. Oncol Rep. 2019;41:2975–2986.
   PubMed Web of Science ®Google Scholar
• Bahrami A, Hasanzadeh M, Hassanian SM, et al. The potential value of the pi3k/akt/mtor signaling pathway for assessing prognosis in cervical cancer and as a target for therapy. J Cell Biochem. 2017;118(12):4163–4169.
   PubMed Web of Science ®Google Scholar